Pharma Journalist - Page 11 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

QIAGEN, NVIDIA Expand AI Drug Discovery Collaboration

Merck Phase 3 Trial Shows Promise in Endometrial Cancer

Takeda Faces $885 Million AMITIZA Antitrust Verdict

Regeneron, Parabilis Partner on Novel Cancer Drug Platform

FDA Grants Breakthrough Status to VERTANICAL Pain Drug

Owkin, AstraZeneca Expand AI Partnership for Drug Development

VOLGA Trial Shows Promise in Muscle-Invasive Bladder Cancer

Arna Pharma, Slate Run Launch U.S. Specialty Pharma Venture

Bristol Myers, Hengrui Forge $15 Billion Drug Development Alliance

EU Approves Pfizer’s HYMPAVZI for Hemophilia Patients With Inhibitors